← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2018Last known activity
Oct 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 4 (5 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT07225387OfficialPhase 4Oct 1, 2024
- NCT07225387Lead sponsorPhase 4Oct 1, 2024
- NCT05535920Study directorPhase 4Apr 14, 2022
- NCT05535920Lead sponsorPhase 4Apr 14, 2022
- NCT05535920Overall official - principal investigatorPhase 4Apr 14, 2022
- NCT04080076Study directorPhase 4Sep 4, 2019
- NCT04080076Lead sponsorPhase 4Sep 4, 2019
- NCT05546047Overall official - principal investigatorPhase 4Mar 14, 2019
- NCT05546047Lead sponsorPhase 4Mar 14, 2019
- NCT05546047Study directorPhase 4Mar 14, 2019
- NCT03502031Reponsible party - principal investigatorPhase 4Mar 1, 2018
- NCT03502031Lead sponsorPhase 4Mar 1, 2018
Details
- Last known activity
- Oct 1, 2024